{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:00:22Z","timestamp":1776078022772,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274512"],"award-info":[{"award-number":["82274512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2022 Joint funding of Guangzhou Science and Technology Bureau and Guangdong Provincial hospital","award":["202201020327"],"award-info":[{"award-number":["202201020327"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Ubiquitin Conjugating Enzyme 2C (UBE2C) is an emerging target gene for tumor progression. However, the tumorigenic effect and mechanism of UBE2C in adrenocortical carcinoma (ACC) remains unclear. Systematic investigation of the tumorigenic effect of UBE2C may help in understanding its prognostic value in adrenocortical carcinoma. First, we exploited the intersection on DFS-related genes, OS-related genes, highly expressed genes in adrenocortical carcinoma as well as differentially expressed genes (DEGs) between tumor and normal, and then obtained 20 candidate genes. UBE2C was identified to be the most significant DEG between tumor and normal. It is confirmed that high expression of UBE2C was strongly associated with poor prognosis in patients with ACC by analyzing RNA-seq data of ACC obtained from the Cancer Genome Atlas (TCGA) database implemented by <jats:italic>ACLBI Web-based Tools<\/jats:italic>. UBE2C expression could also promote m6A modification and stemness in ACC. We found that UBE2C expression is positively associated with the expression of CDC20, CDK1, and CCNA2 using <jats:italic>ACLBI Web-based Tools<\/jats:italic>, indicated the hyperactive cell cycle progression present in ACC with high UBE2C expression. In addition, UBE2C knockdown could significantly inhibit the proliferation, migration, invasion, EMT of adrenocortical carcinoma cells as well as the cell cycle progression in vitro. Notably, pan-cancer analysis also identified UBE2C as an oncogene in various tumors. Taken together, UBE2C was strongly associated with poor prognosis of patients with ACC by promoting cell cycle progression and EMT. This study provides a new theoretical basis for the development of UBE2C as a molecular target for the treatment of ACC.<\/jats:p>","DOI":"10.1371\/journal.pone.0289418","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T17:27:00Z","timestamp":1691083620000},"page":"e0289418","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma"],"prefix":"10.1371","volume":"18","author":[{"given":"Renlun","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-3432","authenticated-orcid":true,"given":"Songtao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"issue":"19","key":"pone.0289418.ref001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13195001","article-title":"Metabolic and Endocrine Toxicities of Mitotane: A Systematic Review.","volume":"13","author":"M Bianchini","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"6","key":"pone.0289418.ref002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: a clinician\u2019s update.","volume":"7","author":"M Fassnacht","year":"2011","journal-title":"Nature reviews Endocrinology"},{"issue":"2","key":"pone.0289418.ref003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"M Fassnacht","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"pone.0289418.ref004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bjs.10414","article-title":"European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma.","volume":"104","author":"S Gaujoux","year":"2017","journal-title":"The British journal of surgery."},{"issue":"2","key":"pone.0289418.ref005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00423-011-0866-8","article-title":"Adrenocortical carcinoma: effect of hospital volume on patient outcome","volume":"397","author":"CP Lombardi","year":"2012","journal-title":"Langenbeck\u2019s archives of surgery"},{"issue":"3","key":"pone.0289418.ref006","doi-asserted-by":"crossref","first-page":"101415","DOI":"10.1016\/j.beem.2020.101415","article-title":"New perspectives for mitotane treatment of adrenocortical carcinoma","volume":"34","author":"S Puglisi","year":"2020","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"issue":"1","key":"pone.0289418.ref007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","article-title":"The role of ubiquitination in tumorigenesis and targeted drug discovery.","volume":"5","author":"L Deng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"pone.0289418.ref008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2013.11.023","article-title":"Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker","volume":"47","author":"C Xie","year":"2014","journal-title":"The international journal of biochemistry & cell biology"},{"issue":"1","key":"pone.0289418.ref009","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12967-022-03641-y","article-title":"CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2\/M phase transition, and PANoptosis.","volume":"20","author":"L Ren","year":"2022","journal-title":"Journal of translational medicine"},{"key":"pone.0289418.ref010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jss.2022.03.022","article-title":"Spindle and Kinetochore-Associated Complex Is Associated With Poor Prognosis in Adrenocortical Carcinoma","volume":"277","author":"S Yu","year":"2022","journal-title":"J Surg Res"},{"issue":"4","key":"pone.0289418.ref011","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162434","article-title":"The UBE2C\/CDH1\/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells","volume":"133","author":"S Zhang","year":"2023","journal-title":"The Journal of clinical investigation"},{"issue":"9","key":"pone.0289418.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092228","article-title":"A Comprehensive Bioinformatics Analysis of UBE2C in Cancers","volume":"20","author":"H Dastsooz","year":"2019","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"pone.0289418.ref013","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation","volume":"173","author":"TM Malta","year":"2018","journal-title":"Cell"},{"issue":"4","key":"pone.0289418.ref014","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41419-020-2435-y","article-title":"CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating beta-catenin\/STAT3 signaling.","volume":"11","author":"R Huang","year":"2020","journal-title":"Cell Death Dis."},{"key":"pone.0289418.ref015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2019.01371","article-title":"XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages\/C-X-C Motif Chemokine Ligand 1 Pathway.","volume":"10","author":"S Wang","year":"2019","journal-title":"Frontiers in pharmacology."},{"issue":"1","key":"pone.0289418.ref016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","article-title":"Molecular characterization and clinical relevance of m(6)A regulators across 33 cancer types.","volume":"18","author":"Y Li","year":"2019","journal-title":"Molecular cancer"},{"issue":"7","key":"pone.0289418.ref017","article-title":"Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data.","volume":"12","author":"J Wei","year":"2020","journal-title":"Cancers"},{"issue":"D1","key":"pone.0289418.ref018","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"D Szklarczyk","year":"2017","journal-title":"Nucleic acids research"},{"issue":"1","key":"pone.0289418.ref019","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41467-018-07185-y","article-title":"Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN","volume":"9","author":"B Liu","year":"2018","journal-title":"Nature communications"},{"issue":"2","key":"pone.0289418.ref020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"MH Glickman","year":"2002","journal-title":"Physiological reviews"},{"issue":"6467","key":"pone.0289418.ref021","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"C Pohl","year":"2019","journal-title":"Science (New York, NY)."},{"issue":"6","key":"pone.0289418.ref022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41389-018-0054-6","article-title":"Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression.","volume":"7","author":"J Guo","year":"2018","journal-title":"Oncogenesis"},{"issue":"18","key":"pone.0289418.ref023","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/15384101.2017.1356507","article-title":"Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death","volume":"16","author":"L Guo","year":"2017","journal-title":"Cell cycle (Georgetown, Tex)."},{"issue":"6","key":"pone.0289418.ref024","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/annonc\/mdr527","article-title":"Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study","volume":"23","author":"A Psyrri","year":"2012","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology."},{"issue":"2","key":"pone.0289418.ref025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1083\/jcb.201301130","article-title":"Panta rhei: the APC\/C at steady state","volume":"201","author":"I Primorac","year":"2013","journal-title":"J Cell Biol"},{"issue":"1","key":"pone.0289418.ref026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41421-021-00368-w","article-title":"KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge.","volume":"8","author":"Z Mao","year":"2022","journal-title":"Cell discovery"},{"issue":"3","key":"pone.0289418.ref027","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-022-06531-5","article-title":"Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.","volume":"192","author":"Y Kariri","year":"2022","journal-title":"Breast cancer research and treatment"},{"issue":"4","key":"pone.0289418.ref028","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00432-020-03147-4","article-title":"Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics","volume":"146","author":"W Guo","year":"2020","journal-title":"Journal of cancer research and clinical oncology"},{"issue":"6","key":"pone.0289418.ref029","first-page":"1665","article-title":"Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients","volume":"22","author":"HQ Zhang","year":"2018","journal-title":"European review for medical and pharmacological sciences"},{"issue":"1","key":"pone.0289418.ref030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"D. Hanahan","year":"2022","journal-title":"Cancer discovery"},{"issue":"20","key":"pone.0289418.ref031","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1097\/CM9.0000000000001708","article-title":"UBE2C affects breast cancer proliferation through the AKT\/mTOR signaling pathway","volume":"134","author":"ZN Lu","year":"2021","journal-title":"Chinese medical journal"},{"key":"pone.0289418.ref032","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.2147\/CMAR.S320393","article-title":"The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer.","volume":"13","author":"Y Wang","year":"2021","journal-title":"Cancer management and research"},{"issue":"2","key":"pone.0289418.ref033","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1158\/1541-7786.MCR-19-0561","article-title":"UBE2C Is Upregulated by Estrogen and Promotes Epithelial-Mesenchymal Transition via p53 in Endometrial Cancer.","volume":"18","author":"Y Liu","year":"2020","journal-title":"Molecular cancer research: MCR."},{"issue":"10","key":"pone.0289418.ref034","article-title":"KAT2A\/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer.","volume":"13","author":"S Lin","year":"2022","journal-title":"Genes"},{"issue":"6","key":"pone.0289418.ref035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13402-013-0150-8","article-title":"Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.","volume":"36","author":"A Rawat","year":"2013","journal-title":"Cellular oncology (Dordrecht)."},{"issue":"24","key":"pone.0289418.ref036","article-title":"Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Inhibit Triple-Negative Breast Cancer Cell Stemness and Metastasis via an ALKBH5-Dependent Mechanism.","volume":"14","author":"Y Hu","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"8","key":"pone.0289418.ref037","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1007\/s10620-019-05916-9","article-title":"MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C\/ZEB1\/2 Signal Axis","volume":"65","author":"M Chen","year":"2020","journal-title":"Digestive diseases and sciences"},{"issue":"17","key":"pone.0289418.ref038","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.18632\/aging.204265","article-title":"UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis","volume":"14","author":"Y Zhou","year":"2022","journal-title":"Aging"},{"key":"pone.0289418.ref039","doi-asserted-by":"crossref","first-page":"647353","DOI":"10.3389\/fgene.2021.647353","article-title":"Identification of Hub Genes and Their Correlation With Immune Infiltration Cells in Hepatocellular Carcinoma Based on GEO and TCGA Databases.","volume":"12","author":"R Huang","year":"2021","journal-title":"Frontiers in genetics"},{"issue":"3","key":"pone.0289418.ref040","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.21037\/jgo-22-516","article-title":"UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation.","volume":"13","author":"JZ Cao","year":"2022","journal-title":"Journal of gastrointestinal oncology."},{"issue":"13","key":"pone.0289418.ref041","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1111\/jcmm.17400","article-title":"UBE2C triggers HIF-1\u03b1-glycolytic flux in head and neck squamous cell carcinoma","volume":"26","author":"YF Yang","year":"2022","journal-title":"Journal of cellular and molecular medicine"},{"issue":"1","key":"pone.0289418.ref042","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m(6)A RNA methylation in human cancer.","volume":"18","author":"XY Chen","year":"2019","journal-title":"Molecular cancer"},{"issue":"4","key":"pone.0289418.ref043","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","article-title":"5\u2019 UTR m(6)A Promotes Cap-Independent Translation.","volume":"163","author":"KD Meyer","year":"2015","journal-title":"Cell"},{"issue":"6","key":"pone.0289418.ref044","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.","volume":"161","author":"X Wang","year":"2015","journal-title":"Cell"},{"issue":"7481","key":"pone.0289418.ref045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"X Wang","year":"2014","journal-title":"Nature"},{"issue":"1","key":"pone.0289418.ref046","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12943-022-01704-8","article-title":"m(6)A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion.","volume":"22","author":"X Cao","year":"2023","journal-title":"Molecular cancer"},{"issue":"6","key":"pone.0289418.ref047","doi-asserted-by":"crossref","first-page":"e1003531","DOI":"10.1371\/journal.pgen.1003531","article-title":"PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation","volume":"9","author":"MI Rodr\u00edguez","year":"2013","journal-title":"PLoS genetics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T17:27:49Z","timestamp":1691083669000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289418"}},"subtitle":[],"editor":[{"given":"Romi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0289418","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]}}}